SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study
Joshua A. Hill(Seattle Pacific University), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Kinga Hosszu, Mehdi Hamadani(Medical College of Wisconsin), John M. McCarty(Virginia Commonwealth University), Kavita V. Bhavsar(Medical College of Wisconsin), Elad Sharon(National Cancer Institute), Uroosa Ibrahim(Mount Sinai Hospital), Susan DeWolf(Memorial Sloan Kettering Cancer Center), Lik Wee Lee(Institute for Systems Biology), Aliyah Baluch(Moffitt Cancer Center), Zainab Shahid(Memorial Sloan Kettering Cancer Center), Lee M. Greenberger(Enzon Pharmaceuticals (United States)), Joseph P. McGuirk(University of Kansas Medical Center), Stephanie Waldvogel(National Marrow Donor Program), Jo‐Anne H. Young(University of Minnesota System), Ashley Spahn(National Marrow Donor Program), Kristin Peyton(Emmes (United States)), Jianqun Kou(East Tennessee State University), Paul M. Armistead(University of North Carolina at Chapel Hill), Dianna S. Howard(Atrium Health Wake Forest Baptist), Jeffery J. Auletta(Nationwide Children's Hospital), Amir A. Toor(Virginia Commonwealth University), Ryotaro Nakamura(City Of Hope National Medical Center), Madhav V. Dhodapkar(Emory University), Mary M. Horowitz(Medical College of Wisconsin), Min Chen, Michael J. Martens(Medical College of Wisconsin), Peter Westervelt(MACOM (United States)), Marcie Riches(Medical College of Wisconsin)
Cited by 25
Related Papers
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968